// App-Quantinova.ai

479 : The display of pro-thrombotic phenotype of mice carrying the BDNF Val66Met human polymorphism is prevented by treatment with Resveratrol

Researchers

Presenter

  • P. Amadio

Principal Investigators

  • S. Gianellini

  • E. Tarantino

  • A. Ieraci

  • M. Brioschi

  • C. Banfi

  • F.S. Lee

  • E. Tremoli

  • S.S. Barbieri

Medical Centers

  • Centro Cardiologico Monzino IRCCS, Milan, Italy

  • Department of Pharmacological and Biomolecular Sciences, Universit degli Studi di Milano, Milan, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Depression

  • Venous thrombosis

Biomarkers

  • Brain-derived neurotrophic factor

  • Hepatocyte growth factor receptor

  • Thrombospondin-1

  • Sirtuin 1

Drug/Treatment

  • Resveratrol

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved